These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF. Sirois P; Harczy M; Braquet P; Borgeat P; Maclouf J; Pradelles P Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1033-7. PubMed ID: 2823554 [No Abstract] [Full Text] [Related]
3. [Physiology of the interactions of blood and the blood vessel wall. Role of pharmacologically active lipids]. Hemmendinger S; d'Humières S; Russo-Marie F; Cazenave JP Arch Mal Coeur Vaiss; 1985 Dec; 78 Spec No():29-36. PubMed ID: 3938941 [TBL] [Abstract][Full Text] [Related]
4. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs. Lellouch-Tubiana A; Lefort J; Pirotzky E; Vargaftig BB; Pfister A Br J Exp Pathol; 1985 Jun; 66(3):345-55. PubMed ID: 3890915 [TBL] [Abstract][Full Text] [Related]
5. Anaphylactic release of platelet activating factor acether and eicosanoids from lungs of guinea pigs sensitized to ovalbumin aerosol. Parente L; Fitzgerald MF; Moncada S Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():171-6. PubMed ID: 2821756 [No Abstract] [Full Text] [Related]
6. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor. Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114 [TBL] [Abstract][Full Text] [Related]
7. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs. Fitzgerald MF; Moncada S; Parente L Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213 [TBL] [Abstract][Full Text] [Related]
8. Histamine release from rabbit platelets by platelet-activating factor (PAF). Nakahodo K; Saitoh S; Nakamura M; Kosugi T Arerugi; 1994 Mar; 43(3):501-10. PubMed ID: 7515227 [TBL] [Abstract][Full Text] [Related]
9. [Cell membrane and phospholipids]. Chap H; Douste-Blazy L Arch Mal Coeur Vaiss; 1985 Dec; 78 Spec No():13-9. PubMed ID: 3938939 [TBL] [Abstract][Full Text] [Related]
10. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances. Vargaftig BB; Joseph D; Marlas G; Chevance LG Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345 [TBL] [Abstract][Full Text] [Related]
11. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine. Chignard M; Le Couedic JP; Coëffier E; Benveniste J Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404 [TBL] [Abstract][Full Text] [Related]
12. The PAF-acether receptor antagonist BN-52021 inhibits mediator release during guinea-pig active lung anaphylaxis. Berti F; Galli G; Magni F; Rossoni G; Villa L; Puglisi L; Pasargiklian R; Braquet P Pharmacol Res Commun; 1988 Dec; 20(12):1047-59. PubMed ID: 2463644 [TBL] [Abstract][Full Text] [Related]
13. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation. Zhang M; Zhang LZ; Lu JS Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812 [TBL] [Abstract][Full Text] [Related]
14. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [TBL] [Abstract][Full Text] [Related]
15. Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. Pinckard RN; Halonen M; Palmer JD; Butler C; Shaw JO; Henson PM J Immunol; 1977 Dec; 119(6):2185-93. PubMed ID: 915295 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions. Lefort J; Wal F; Chignard M; Medeiros MC; Vargaftig BB Agents Actions; 1982 Dec; 12(5-6):723-5. PubMed ID: 7164948 [TBL] [Abstract][Full Text] [Related]
17. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995 [TBL] [Abstract][Full Text] [Related]
18. The role of immunomodulators in the production of lipid mediators by macrophages (M phi). Roubin R; Drapier JC; Petit JF; Benveniste J Int J Tissue React; 1984; 6(5):373-8. PubMed ID: 6596298 [TBL] [Abstract][Full Text] [Related]
19. Effects of the released mediators of anaphylaxis on the target organs. Piper PJ Scand J Respir Dis Suppl; 1977; 98():40-6. PubMed ID: 72410 [TBL] [Abstract][Full Text] [Related]
20. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride. Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]